Biotechnology, Pharma and Healthcare Market Research +91 70133 15430 info@ameyamrs.com

8 reports

AM-RS-017

Adeno-Associated Virus Vectors

AAV vectors are studied by serotype and capsid engineering approach, covering research-grade and clinical-grade supply for gene therapy. The report assesses production systems, purification…

November 2026 edition From US$3,000
AM-RS-021

Antibody-Drug Conjugates

Antibody-drug conjugates are studied by target, linker and payload class, with oncology indications leading the analysis. The report reviews approved ADCs, the clinical pipeline…

November 2026 edition From US$3,400
AM-RS-022

Chimeric Antigen Receptor T-Cell Therapy

CAR-T therapy is examined across autologous and allogeneic products, target antigens and indications in hematologic and solid tumors. The report covers approved therapies, manufacturing and…

November 2026 edition From US$3,400
AM-RS-024

Immune Tolerance Therapy

Immune tolerance therapy is studied as an emerging approach for autoimmune disease, allergy and transplantation that restores tolerance rather than suppressing immunity broadly…

November 2026 edition From US$2,800
AM-RS-020

Prime Editing

Prime editing is reviewed as a precise gene-editing technology able to write targeted insertions, deletions and substitutions without double-strand breaks. The study covers editor design…

November 2026 edition From US$3,200
AM-RS-023

Therapeutic Exosomes

Therapeutic exosomes are reviewed as a discovery-stage modality for drug delivery, regenerative medicine and immunotherapy. The study covers isolation and loading methods, engineered…

November 2026 edition From US$2,800

Leave a Message

Unsubscribe